CausalSentinel

Protein Dossier — AKR7A2 (Aflatoxin B1 aldehyde reductase member 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: M23 Internal derangement of knee 0.196 0.054 2.88e-04 Wald ratio 1 cis NA
Diagnoses - main ICD10: M17 Gonarthrosis [arthrosis of knee] 0.176 0.0591 0.00287 Wald ratio 1 cis NA
Fractured bone site(s): Arm 0.222 0.0791 0.00494 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter 0.242 0.092 0.00855 Wald ratio 1 cis NA
Body fat 0.0679 0.0266 0.0107 Wald ratio 1 cis NA
Non-cancer illness code self-reported: pernicious anaemia 0.327 0.132 0.0132 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years 0.0639 0.0285 0.0253 Wald ratio 1 cis NA
Body mass index (BMI) 0.0215 0.00974 0.0274 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis 0.231 0.113 0.0408 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis 0.0624 0.0307 0.0418 Wald ratio 1 cis NA
Fractured bone site(s): Other bones 0.0796 0.0392 0.0425 Wald ratio 1 cis NA
2hr glucose 0.167 0.0826 0.0426 Wald ratio 1 cis NA
…and 84 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4188_1_2 Aflatoxin B1 aldehyde reductase Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

17 association rows across 14 traits (15 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Urine X-24462 levels in chronic kidney disease 9e-991 rs75708060 1 GCST90266727 no MR -> candidate analysis
Plasma X-24462 levels in chronic kidney disease 2e-779 rs75708060 1 GCST90266726 no MR -> candidate analysis
X-24462 levels 4e-426 rs75708060 1 GCST90140598 no MR -> candidate analysis
Urinary metabolite levels in chronic kidney disease 2e-412 rs1043657 1 GCST009733 no MR -> candidate analysis
Aflatoxin B1 aldehyde reductase member 2 levels 4e-46 rs116348652 3 GCST90137642 no MR -> candidate analysis
Serum levels of protein AKR7A2 1e-41 rs143187056 2 GCST90088623 no MR -> candidate analysis
AKR7L protein levels 9e-40 rs143187056 1 GCST90468275 no MR -> candidate analysis
Urinary metabolite modules (eigenmetabolites) in chronic kid 2e-26 rs1043657 1 GCST009735 no MR -> candidate analysis
ARK72 protein level (protein group normalized intensity) 2e-21 rs1043657 1 GCST90570779 no MR -> candidate analysis
Aflatoxin B1 aldehyde reductase member 2 level in Chronic ki 4e-19 rs79253438 1 GCST90237586 no MR -> candidate analysis
Pre-treatment viral load in HIV-1 infection 2e-17 rs859208 1 GCST008758 no MR -> candidate analysis
DNA methylation PhenoAge acceleration 3e-8 rs116348652 1 GCST90014298 no MR -> candidate analysis
…and 2 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 55 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
hypothyroidism 0.111 common-variant locus MR: beta=0.0355, p=0.396 (cis)
cholelithiasis 0.071 common-variant locus no MR -> candidate analysis
kidney disorder 0.053 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Aflatoxin B1 aldehyde reductase member 2)
gnomAD constraint pLI=2e-08, LOEUF=1.06 — LoF-tolerant
GWAS Catalog 48 unique SNPs / 95 rows
ClinVar 101 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance